Evidence map›Paper›PMID 32999020›Full record

ArticleJournal of virology2020

Dengue Virus Targets Nrf2 for NS2B3-Mediated Degradation Leading to Enhanced Oxidative Stress and Viral Replication.

Matteo Ferrari, Alessandra Zevini, Enrico Palermo, Michela Muscolini, Magdalini Alexandridi, Marilena P Etna, Eliana M Coccia, Ana Fernandez-Sesma, Carolyn Coyne, Donna D Zhang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 70 citations in OpenAlex.

  1. The oxidative stress paradigm in arbovirus infections: mechanisms and therapeutic insights.Redox report : communications in free radical research · 2026
    Review
  2. Discovery of 10-Shogaol fromJournal of agricultural and food chemistry · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. ROS Induced byMarine drugs · 2024
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Matteo FerrariPasteur Laboratory, Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, Italy.
Alessandra ZeviniPasteur Laboratory, Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, Italy.
Enrico PalermoPasteur Laboratory, Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, Italy.
Michela MuscoliniPasteur Laboratory, Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, Italy.
Magdalini AlexandridiPasteur Laboratory, Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, Italy.
Marilena P EtnaDepartment of Infectious Diseases, Istituto Superiore Sanità, Rome, Italy.
Eliana M CocciaDepartment of Infectious Diseases, Istituto Superiore Sanità, Rome, Italy.
Ana Fernandez-SesmaDepartment of Microbiology, Mt. Sinai School of Medicine, New York, New York, USA.
Carolyn CoyneDepartment of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0002-1884-6309
Donna D ZhangDepartment of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona, USA.
Ernesto T A MarquesDepartment of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
David OlagnierDepartment of Biomedicine, Aarhus University, Aarhus, Denmark olagnier@biomed.au.dk john.hiscott@istitutopasteur.it.
John HiscottPasteur Laboratory, Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, Italy olagnier@biomed.au.dk john.hiscott@istitutopasteur.it.ORCID 0000-0003-2076-6321
Istituto Pasteur · ITIstituto Superiore di Sanità · ITUniversity of Pittsburgh · USAarhus University · DKIcahn School of Medicine at Mount Sinai · USUniversity of Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dengue virus (DENV) is a mosquito-borne virus that infects upward of 300 million people annually and has the potential to cause fatal hemorrhagic fever and shock. While the parameters contributing to dengue immunopathogenesis remain unclear, the collapse of redox homeostasis and the damage induced by oxidative stress have been correlated with the development of inflammation and progression toward the more severe forms of disease. In the present study, we demonstrate that the accumulation of reactive oxygen species (ROS) late after DENV infection (>24 hpi) resulted from a disruption in the balance between oxidative stress and the nuclear factor erythroid 2-related factor 2 (Nrf2)-dependent antioxidant response. The DENV NS2B3 protease complex strategically targeted Nrf2 for degradation in a proteolysis-independent manner; NS2B3 licensed Nrf2 for lysosomal degradation. Impairment of the Nrf2 regulator by the NS2B3 complex inhibited the antioxidant gene network and contributed to the progressive increase in ROS levels, along with increased virus replication and inflammatory or apoptotic gene expression. By 24 hpi, when increased levels of ROS and antiviral proteins were observed, it appeared that the proviral effect of ROS overcame the antiviral effects of the interferon (IFN) response. Overall, these studies demonstrate that DENV infection disrupts the regulatory interplay between DENV-induced stress responses, Nrf2 antioxidant signaling, and the host antiviral immune response, thus exacerbating oxidative stress and inflammation in DENV infection.

Indexed as

A549 CellsAntiviral AgentsCell LineDengueDengue VirusGene Expression Regulation, ViralGene Knockout TechniquesHEK293 CellsHeme Oxygenase-1HumansInterferonsNF-E2-Related Factor 2Oxidative StressReactive Oxygen SpeciesSignal TransductionVirus ReplicationAntiviral AgentsHeme Oxygenase-1HMOX1 protein, humanInterferonsNFE2L2 protein, humanNF-E2-Related Factor 2Reactive Oxygen SpeciesdengueDENVimmunometabolisminflammationinterferonNrf2NS2B3oxidative stress

Identifiers

PMID32999020
PMCPMC7925186
OpenAlexW3089969311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.